Rapport Therapeutics Inc. to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

Reuters
Sep 12
Rapport <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Inc. to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy <a href="https://laohu8.com/S/SMMT">Summit</a>

Rapport Therapeutics Inc., a clinical-stage biotechnology company focused on developing precision medicines for neurological and psychiatric disorders, will participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit. The virtual event will feature a fireside chat with Rapport's management on Wednesday, September 17, 2025, at 11:20 am ET. Interested parties can access the live and archived webcast of the chat via the company's website.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9527763-en) on September 11, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10